Home / Inspections / 1301302

FDA Inspection 1301302 — Genesis Fertility & Reproductive Medicine

Genesis Fertility & Reproductive Medicine — FEI 3003972326

The FDA completed an inspection of Genesis Fertility & Reproductive Medicine on January 27, 2026 in Brooklyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 27, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Brooklyn, NY (United States)

Facility

Other inspections at this facility

  • 1214469 (NAI Fri Aug 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1112313 (NAI Wed Oct 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1075190 (VAI Fri Dec 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 992579 (NAI Fri Nov 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903598 (VAI Thu Nov 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources